chr9-132925714-T-A

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP2BP4

The NM_000368.5(TSC1):​c.236A>T​(p.Tyr79Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

TSC1
NM_000368.5 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.53
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), TSC1. . Gene score misZ 2.3217 (greater than the threshold 3.09). Trascript score misZ 3.6986 (greater than threshold 3.09). GenCC has associacion of gene with lung lymphangioleiomyomatosis, tuberous sclerosis 1, tuberous sclerosis, tuberous sclerosis complex, lymphangioleiomyomatosis.
BP4
Computational evidence support a benign effect (MetaRNN=0.2834985).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TSC1NM_000368.5 linkuse as main transcriptc.236A>T p.Tyr79Phe missense_variant 5/23 ENST00000298552.9 NP_000359.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TSC1ENST00000298552.9 linkuse as main transcriptc.236A>T p.Tyr79Phe missense_variant 5/231 NM_000368.5 ENSP00000298552 P4Q92574-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 18, 2023The p.Y79F variant (also known as c.236A>T), located in coding exon 3 of the TSC1 gene, results from an A to T substitution at nucleotide position 236. The tyrosine at codon 79 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.038
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
22
DANN
Benign
0.89
DEOGEN2
Uncertain
0.44
T;T;.;T;.;T;.;.;.;.;.;.;.;T;.;.
Eigen
Benign
-0.054
Eigen_PC
Benign
0.039
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.93
.;D;D;.;.;.;D;D;.;.;D;D;D;D;D;D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.28
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
2.0
M;M;.;M;.;M;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
D;D;N;N;N
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.40
N;N;.;.;.;.;.;.;.;.;.;.;.;N;.;.
REVEL
Benign
0.14
Sift
Benign
0.44
T;T;.;.;.;.;.;.;.;.;.;.;.;T;.;.
Sift4G
Benign
0.55
T;T;.;.;.;.;.;.;.;.;.;.;.;T;.;.
Polyphen
0.0040
B;B;.;B;.;B;.;.;P;P;P;.;.;P;.;.
Vest4
0.51
MutPred
0.56
Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);Gain of methylation at K82 (P = 0.1125);
MVP
0.57
MPC
1.0
ClinPred
0.69
D
GERP RS
4.2
Varity_R
0.060
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr9-135801101; API